This inventor holds 1 USPTO granted patent. Top assignee: Pharmanetics Incorporated. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Innovations in Coagulation Assays by Gwyn A. Cutsforth
Introduction
Gwyn A. Cutsforth is an accomplished inventor based in Chapel Hill, North Carolina. She has made significant contributions to the field of coagulation assays, showcasing her innovative spirit through her patented work.
Latest Patents
Gwyn A. Cutsforth holds a patent titled "Coagulation assay reagents containing lanthanides." This invention provides a method, kit, system, and reagent for performing coagulation assays with enhanced sensitivity and a greater dynamic range. The technology employs metal compounds that interact with calcium binding sites within the blood coagulation cascade, particularly highlighting the use of lanthanide, manganese, and magnesium compounds. Additionally, her patent introduces a Protein C reagent, kit, and assay method, utilizing similar metal compounds to improve detection sensitivity and dynamic range between samples.
Career Highlights
Gwyn is a key member of Pharmanetics Incorporated, a company that focuses on innovative solutions in the pharmaceutical industry. Her work has been instrumental in advancing the methodologies used in coagulation testing, reflecting her commitment to enhancing healthcare diagnostics.
Collaborations
Throughout her career, Gwyn has collaborated with esteemed colleagues, including Donald E. Mahan. Together, they have contributed to important developments in their field, driving forward the research and practical applications of coagulation assays.
Conclusion
Gwyn A. Cutsforth's innovative contributions to the field of coagulation assays, particularly through her patent involving lanthanide compounds, showcase her role as a leading inventor. Her ongoing work at Pharmanetics Incorporated continues to impact the landscape of medical diagnostics, delivering greater sensitivity and accuracy in coagulation testing.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile